AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
$564M |
| 2 |
Visa
V
|
$317M |
| 3 |
MSCI
MSCI
|
$297M |
| 4 |
Monster Beverage
MNST
|
$266M |
| 5 |
Dollar General
DG
|
$262M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$480M |
| 2 |
Nike
NKE
|
$442M |
| 3 |
Meta Platforms (Facebook)
META
|
$410M |
| 4 |
Advanced Micro Devices
AMD
|
$310M |
| 5 |
Adobe
ADBE
|
$304M |
Sector Composition
| 1 | Technology | 24.78% |
| 2 | Healthcare | 17.69% |
| 3 | Financials | 13.1% |
| 4 | Consumer Discretionary | 10.63% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
CAE Inc
CAE
$8.53B
| $365K | ﹤0.01% |
23,811
-259
| -1% | -$3.97K |
|
2777
Nuvation Bio
NUVB
$1.33B
| $365K | ﹤0.01% |
162,994
| – | – |
|
2778
Pennant Group
PNTG
$840M
| $363K | ﹤0.01% |
34,887
+176
| +0.5% | +$1.83K |
|
2779
Arlo Technologies
ARLO
$1.89B
| $362K | ﹤0.01% |
78,114
+6,794
| +10% | +$31.5K |
|
2780
Stoneridge
SRI
$226M
| $361K | ﹤0.01% |
21,300
| – | – |
|
|
BFS
2781
Saul Centers
BFS
$812M
| $360K | ﹤0.01% |
9,588
+637
| +7% | +$23.9K |
|
2782
BlueLinx
BXC
$680M
| $360K | ﹤0.01% |
5,800
| – | – |
|
2783
ROBO Global Robotics & Automation Index ETF
ROBO
$1.11B
| $360K | ﹤0.01% |
8,711
+3,050
| +54% | +$126K |
|
2784
Ocular Therapeutix
OCUL
$2.37B
| $359K | ﹤0.01% |
86,400
-5,300
| -6% | -$22K |
|
|
SPGS
2785
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
| $355K | ﹤0.01% |
36,000
| – | – |
|
2786
Design Therapeutics
DSGN
$367M
| $354K | ﹤0.01% |
21,200
+7,200
| +51% | +$120K |
|
2787
Greif Class B
GEF.B
$2.5B
| $353K | ﹤0.01% |
5,800
+1,200
| +26% | +$73K |
|
2788
Hackett Group
HCKT
$576M
| $353K | ﹤0.01% |
19,897
+1,300
| +7% | +$23.1K |
|
2789
Stoke Therapeutics
STOK
$1.13B
| $353K | ﹤0.01% |
27,500
+3,800
| +16% | +$48.8K |
|
2790
Arrow Financial
AROW
$483M
| $351K | ﹤0.01% |
12,528
+760
| +6% | +$21.3K |
|
2791
Movado Group
MOV
$431M
| $351K | ﹤0.01% |
12,452
-990
| -7% | -$27.9K |
|
|
PNT
2792
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $348K | ﹤0.01% |
45,000
+31,800
| +241% | +$246K |
|
2793
Rigel Pharmaceuticals
RIGL
$742M
| $347K | ﹤0.01% |
29,444
| – | – |
|
2794
Gorman-Rupp
GRC
$1.14B
| $346K | ﹤0.01% |
14,537
-5,425
| -27% | -$129K |
|
2795
SPDR Bloomberg High Yield Bond ETF
JNK
$8.1B
| $346K | ﹤0.01% |
+3,935
| New | +$346K |
|
2796
Nova
NVMI
$7.58B
| $346K | ﹤0.01% |
+4,060
| New | +$346K |
|
2797
Alamos Gold
AGI
$13.5B
| $345K | ﹤0.01% |
46,519
+27,300
| +142% | +$202K |
|
2798
Community Health Systems
CYH
$409M
| $345K | ﹤0.01% |
160,420
-180,427
| -53% | -$388K |
|
2799
Ocugen
OCGN
$322M
| $344K | ﹤0.01% |
193,200
| – | – |
|
2800
Rackspace Technology
RXT
$335M
| $344K | ﹤0.01% |
84,286
-221
| -0.3% | -$902 |
|